Case :6364 Advised Date :07/12/2023 11:25:22 AM

Name :Mr. RAMAN SINGH Patient Code :PH0004402539

Age :34 (Y)/0 (M)/0 (D) Advised By :Dr. ANKUR N. GUPTA
Gender :Male Mode of Delivery :Self

COMPLETE HAEMOGRAM

Test Result Unit BRI/RangeValue

HAEMOGLOBIN (Hb) 13.8 gm/dl 12 - 17

TOTAL LEUCOCYTE COUNT (TLC) 5600 /cumm 4000 - 11000
DIFFERENTIAL LEUCOCYTE COUNT (DLC)
NEUTROPHIL 53 % 40 - 75
LYMPHOCYTE 37 % 20 - 45
EOSINOPHIL 06 % 1-6
MONOCYTE 04 % 2 - 10
BASOPHIL 0.00 %
ERYTHROCYTE SED.RATE (Westergren`s) 10 mm/Ist hr. 5 - 10
PLATELET COUNT 1.64 lacs/cumm 1.5 - 4.5
R B C COUNT 4.20 millions/cmm 4.5 - 5.5
P.C.V / HAEMATOCRIT 40.5 % 35 - 45
MCV 96.43 fl. 80 - 100
MCH 32.86 Picogram 27 - 31
MCHC 34.07 gm/dl 33 - 37

Dr. Sarandeep Singh Puri

M.D. PATH
Case :6364 Advised Date :07/12/2023 11:25:22 AM
Name :Mr. RAMAN SINGH Patient Code :PH0004402539
Age :34 (Y)/0 (M)/0 (D) Advised By :Dr. ANKUR N. GUPTA
Gender :Male Mode of Delivery :Self

LIVER FUNCTION TEST (LFT)

Test Result Unit BRI/RangeValue

BILIRUBIN TOTAL 0.71 MG/DL 0-1

CONJUGATED (D. Bilirubin) 0.31 MG/DL 0 - 0.35
UNCONJUGATED (I.D.Bilirubin) 0.40 MG/DL 0.2 - 0.65
SGOT (AST) 37 IU/L 10 - 40
SGPT (ALT) 43 IU/L 10 - 40
ALKALINE PHOSPHATASE 83 U/L 40 - 112
TOTAL PROTEIN 7.0 gm/dl 6 - 8.5
ALBUMIN 4.0 gm/dl 3.5 - 5
GLOBULIN 3.0 gm/dl 2 - 3.5
A/G RATIO 1.3

Dr. Sarandeep Singh Puri

M.D. PATH
Case :6364 Advised Date :07/12/2023 11:25:22 AM
Name :Mr. RAMAN SINGH Patient Code :PH0004402539
Age :34 (Y)/0 (M)/0 (D) Advised By :Dr. ANKUR N. GUPTA
Gender :Male Mode of Delivery :Self

LIPID PROFILE

Test Result Unit BRI/RangeValue

TOTAL CHOLESTEROL 175 MG/DL 150 - 200

TRIGLYCERIDES 88 mg /dl 40 - 140
H D L CHOLESTEROL DIRECT 48 MG/DL 35 - 70
VLDL 17.60 MG/DL 5 - 35
L D L CHOLESTEROL DIRECT 119 MG/DL 60 - 130
TOTAL CHOLESTEROL/HDL RATIO 3.65 0 - 4.5
LDL / HDL CHOLESTEROL RATIO 2.48 0 - 3.55

TRIGLYCERIDE level > 250mg/dL is associated with an approximately 2-fold greater risk of coronary vascular disease.
Elevation of triglycerides can be seen with obesity, medication, fast less than 12 hrs., alcohol intake, diabetes melitus,and
pancreatitis.
CHOLESTEROL, its fractions and triglycerides are the important plasma lipids indefining cardiovascular risk factors and in
the managment of cardiovascular disease.Highest acceptable and optimum values of cholesterol values of cholesterol vary
with age. Values above 220 mgm/dl are associated with increased risk of CHD regardless of HDL & LDL values.
HDL-CHOLESTEROL level <35 mg/dL is associated with an increased risk of coronary vascular disease even in the face of
desirable levels of cholesterol and LDL - cholesterol.
LDL - CHOLESTEROL& TOTAL CHOLESTEROL levels can be strikingly altered by thyroid, renal and liver disease as well
as hereditary factors.Based on total cholesterol, LDL- cholesterol, and total cholesterol/HDL - cholesterol ratio, patients may
be divided into the three risk categories :

CHOLESTEROL LDL-CHOLESTEROL CHO/HDL RATIO

Acceptable/Low Risk: < 200 mg/dl < 130 mg/dl < 4.5
Borderline High Risk: 200-239 mg/dl 130-159 mg/dl 4.5-6.0
High Risk: > 240 mg/dl >160 mg/dl >6.0

APO A1 & APO B: Recent studies have shon that Apolipoproteins A1 & B might be the best Indicators of Coronary Artey
Disease risk in an Individual. Patients who have normal lipid profile may have abnormal Apo & Apo B values. Ratio of Apo B :
Apo A1 is >1 in cases of increased CHD risk.

Dr. Sarandeep Singh Puri

M.D. PATH
Case :6364 Advised Date :07/12/2023 11:25:22 AM
Name :Mr. RAMAN SINGH Patient Code :PH0004402539
Age :34 (Y)/0 (M)/0 (D) Advised By :Dr. ANKUR N. GUPTA
Gender :Male Mode of Delivery :Self

THYROID PROFILE

Test Result Unit BRI/RangeValue

TSH 7.50 uIU/ml 0.35 - 6

Note:

TSH levels are subject to circadian variation, reaching peak levels between 2 - 4 AM and at a minimum between 6 - 10 PM. The variation is of the
order of 50%, hence time of the day has influence on the measured serum TSH concentrations. Dose and time of drug intake also influence the test
result.

COMMENT :
THE LEVELS OF THYROID HORMONE (T3 & T4) ARE LOW IN CASE OF PRIMARY, SECONDRY AND TERTIARY
HYPOTHYROIDISM AND SOMETIMES IN NONTHYROIDAL ALSO. INCREASED LEVELS ARE FOUND IN GRAVE - S
DISEASE, HYPERTHYROIDISM AND THYROID HORMONE RESISTANCE. T3 LEVELS ARE ALSO RAISED IN T3
THYROTOXICOSIS. TSH LEVELS ARE RAISED IN PRIMARY HYPOTHYRODISM AND LOW IN HYPERHYROIDISM AND
SECONDARY HYPOTHROIDISM.

Dr. Sarandeep Singh Puri

M.D. PATH
Case :6364 Advised Date :07/12/2023 11:25:22 AM
Name :Mr. RAMAN SINGH Patient Code :PH0004402539
Age :34 (Y)/0 (M)/0 (D) Advised By :Dr. ANKUR N. GUPTA
Gender :Male Mode of Delivery :Self

SPECIAL HAEMATOLOGY

Test Result Unit BRI/RangeValue

HBA1C 5.8 % 0-7

HB A1c VALUE INTERPRETATIONS
<6% Non Diabetic level / Normal
6-7% Good Diabetic control
7-8% Fair Diabetic control
>8% Uncantrolled Diabetic - action suggested

HbA1c assay has been validated as a reliable indicator of mean blood glucose levels for a period of 8 - 12 week. American Diabetic Association recommends
the testing twice a year in patients with good control and quaterly in other cases . Result of HbA1c should be assessed in conjuction with the patient's medical
history, clinical examinations and other findings.

Averave sugar as per HbA1c 120.0 mg/dl

TO BE CORRELATED CLINICALLY.

Dr. Sarandeep Singh Puri

M.D. PATH
Case :6364 Advised Date :07/12/2023 11:25:22 AM
Name :Mr. RAMAN SINGH Patient Code :PH0004402539
Age :34 (Y)/0 (M)/0 (D) Advised By :Dr. ANKUR N. GUPTA
Gender :Male Mode of Delivery :Self

BIOCHEMISTRY ROUTINE

Test Result Unit BRI/RangeValue

BLOOD SUGAR FASTING 105 MG/DL 60 - 110

***End of Report***

Dr. Sarandeep Singh Puri

M.D. PATH